A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke

[Ketua Dobbs]

A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke

Patients at high risk for a heart attack or stroke who took an investigational drug in addition to a statin had significantly lower LDL, or "bad" cholesterol, after 12 weeks compared to similar patients who took a placebo in addition to statin therapy, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.
Source: A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke